News | January 11, 2024
Lupin launches Varenicline Tablets in US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Varenicline Tablets (RLD Chantix) had estimated annual sales of US $412 million in the US
Bromfenac Ophthalmic Solution, 0.07% is the generic equivalent of Prolensa Ophthalmic Solution, 0.07%, of Bausch & Lomb
Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in Aptivate Champion Run
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Loteprednol Etabonate Ophthalmic Suspension, 0.2%, is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
Sitagliptin Tablets USP, 25 mg, 50 mg, and 100 mg are indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus
The product will be manufactured at Lupin's Pithampur facility in India
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)